Printer Friendly
The Free Library
14,717,670 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Europe's Largest Biotech Event Moves to Olympia; International Biotech to Also Co-Host Lab Automation Europe.


Business Editors/Health/Medical Writers

International Biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 

LONDON--(BUSINESS WIRE)--March 27, 2003

IIR IIR - Infinite Impulse Response , a leading global conference and exhibition organiser have today announced their decision to relocate re·lo·cate  
v. re·lo·cat·ed, re·lo·cat·ing, re·lo·cates

v.tr.
To move to or establish in a new place: relocated the business.

v.intr.
 International Biotech, Europe's only International Biotechnology event, to Olympia in Kensington, London. Through offering an easily accessible venue in the centre of a busy biotechnology area, the show organisers anticipate that this year's show will attract even more visitors and exhibitors. The show will take place on the 25th and 26th of November.

Last years' event, featuring 150 exhibitors as well as an extensive range of seminars and a high-level conference agenda was extremely successful, attracting over 1,700 visitors. Following on from the huge success, the organisers are planning to make this years' show even bigger and better. Thermo electron Thermo Electron Corporation (TMO (NYSE)) (incorporated 1956) is a major provider of analytical instruments and services for a variety of domains.

Thermo has revenues of over $2 billion, and employs 11,000 people in 30 countries.
, an exhibitor at last year's event, are very much looking forward to this years show, "The combined forum of International Biotech and Lab Automation Europe provides the ideal opportunity for Thermo Electron Corporation to highlight its broad range of life and laboratory instrumentation instrumentation, in music: see orchestra and orchestration.
instrumentation

In technology, the development and use of precise measuring, analysis, and control equipment.
 and integrated technology" commented Alison Hebbes, European Marketing Manager.

Feedback given by last year's exhibitors and show visitors indicated that a more central location, with a closer proximity to London's numerous academic and research centres would be more desirable. Olympia has proven to be the obvious venue of choice, not only is it within easy reach of many biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
; it also has several universities nearby. In addition, Olympia's National Hall provides the ideal setting for the additional seminars and workshops that IIR is planning.

There will be added dimension to this year's show as Lab Automation Europe is co-locating with International Biotech. Lab Automation Europe is a brand new event, which will provide a dedicated forum for the dynamic automation technology sector. The event will feature around 50 exhibitors and a comprehensive programme of educational workshops and seminars.

International Biotech and Lab Automation Europe together provide the perfect opportunity to be at the cutting edge of technology and a forum for trade, partnership and information exchange. Admission to both shows is free of charge to visitors.

Organisations from across the biotechnology community will be exhibiting at International Biotech, from molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller  to proteomics pro·te·o·mics
n.
The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism.
, from drug discovery and development to clinical trials and production. Companies should contact Greg Cherry, Event Manager on +44(0)207 915 5541 for more information about exhibiting.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 27, 2003
Words:394
Previous Article:Fifth Product Using Nektar Technology Approved in U.S.; FDA Approves Pharmacia Corporation's SOMAVERT for the Treatment of Acromegaly.
Next Article:Coca-Cola Enterprises Inc. to Webcast Credit Suisse First Boston Global Beverages and Tobacco Conference Presentation.



Related Articles
Molina Opposes Plan for Larger Biotech Facility.(Gloria Molina)(Brief Article)
Brave new food: biotech vaccines in our corn and greens: Debi Athos questions the logic of feeding pharmaceutical fruits and vegetables to the...
GPC BIOTECH GETS U.S. PATENT FOR ANTI-CANCER CELL INHIBITOR.
IDG sells Bio-IT World, Inc. to Cambridge Healthtech Institute.
SATRAPLATIN REDUCES RISK OF PROSTATE CANCER PROGRESSION.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles